Todd M Cleveland, Executive Board Chairman at Patrick Industries (NASDAQ:PATK), made a large insider sell on October 1, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Cleveland sold 10,000 shares of Patrick Industries at a price of $87.46. The total transaction amounted to $874,621.

Following the transaction, Cleveland still owns 454,893 shares of the company, worth $38,056,348.

Patrick Industries shares are trading down 2.12% at $83.66 at the time of this writing on Wednesday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Why Insider Transactions Are Important

Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Important Transaction Codes

Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.

Check Out The Full List Of Patrick Industries's Insider Trades.

See more from Benzinga

  • Click here for options trades from Benzinga

  • Chief Commercial Officer Of Corcept Therapeutics Trades 0K In Company Stock

  • President And Co-CEO Of American Well Trades 0K In Company Stock

© 2021 Benzinga does not provide investment advice. All rights reserved.

(305) 707 0888